STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24-Month Results of a Randomized, Double-Masked, Vehicle-Controlled Trial of Atropine Sulfate 0.01% and 0.03%

Abstract Introduction Pediatric myopia is rising globally, with high myopia associated with sight-threatening complications later in life. Low-dose atropine has been shown to slow myopia progression, with most studies conducted in Asian populations using compounded formulations. We evaluated the eff...

Descripció completa

Dades bibliogràfiques

Autors principals:	Michael Korenfeld, Maria Hurcikova, Kay Tatsuoka, Dana Tomciková, Janet Cheetham, Marek Kacerik, on behalf of the STAR Study Investigators
Format:	Artigo
Idioma:	Inglês
Publicat:	Adis, Springer Healthcare 2026-03-01
Col·lecció:	Ophthalmology and Therapy
Matèries:	Annual progression rate APR Atropine sulfate 0.01% Atropine sulfate 0.03% Children Low-dose atropine
Accés en línia:	https://doi.org/10.1007/s40123-026-01341-0
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!